Melbourne, Australia, 5 November 2019 – Mark Sullivan, Managing Director and Founder of Medicines Development for Global Health, was awarded one of EY Australia’s “Entrepreneur of the Year” awards in the social category for his work in establishing MDGH. The MDGH business model was singled out by the judging committee as “an exciting new way to develop, register, and deliver medicines for neglected diseases, providing a model for other biopharmaceutical companies to become involved.”
Awarded annually since 2001, the award program has recognized over 1500 Australian entrepreneurs for their accomplishments. According to EY, the program “recognises and celebrates the spirit and contribution of exceptional entrepreneurs. These are the individuals who see things beyond the horizon and help shape the future. By challenging orthodox methods and creating new markets for goods and services, entrepreneurs positively disrupt the way we do business and help enhance our quality of life.”
Read more at EY.com.
About Medicines Development for Global Health
MDGH is a not-for-profit biopharmaceutical company headquartered in Melbourne, Australia. Established in 2005, this unique organization is dedicated to the development of affordable medicines and vaccines for neglected diseases prevalent in low- and middle-income countries. The company works on the development of a portfolio of products, including vaccines, small molecules and biological therapies targeting predominantly infectious, immunologic, and oncologic diseases. For additional information about MDGH, please visit www.medicinesdevelopment.com.